Universitaetsklinikum Frankfurt Goethe-Universitaet

Frankfurt am Main 60590

3 studies enrolling now · 3 studies all time

What they study most

Gastric Cancer, Gastroesophageal Junction Cancer, Moderately to Severely Active Crohn Disease, Small Cell Lung Cancer

Studies at this site

• Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer — Recruiting now
• A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer — Recruiting now
• Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease — Recruiting now